Alici S - Search Results

1

Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors.

Alici S, Bavbek SE, Kaytan E, Başaran M, Eralp Y, Onat H. Alici S, et al. Am J Clin Oncol. 2002 Oct;25(5):502-8. doi: 10.1097/00000421-200210000-00016. Am J Clin Oncol. 2002. PMID: 12393993

2

Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.

Tas F, Aykan F, Alici S, Kaytan E, Aydiner A, Topuz E. Tas F, et al. Among authors: alici s. Am J Clin Oncol. 2001 Dec;24(6):547-50. doi: 10.1097/00000421-200112000-00003. Am J Clin Oncol. 2001. PMID: 11801751

3

Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.

Basaran M, Bavbek ES, Sakar B, Eralp Y, Alici S, Tas F, Yaman F, Dogan O O, Camlica H, Onat H. Basaran M, et al. Among authors: alici s. Am J Clin Oncol. 2001 Dec;24(6):570-5. doi: 10.1097/00000421-200112000-00008. Am J Clin Oncol. 2001. PMID: 11801756 Clinical Trial.

4

Anemia in oncology practice: relation to diseases and their therapies.

Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E. Tas F, et al. Among authors: alici s. Am J Clin Oncol. 2002 Aug;25(4):371-9. doi: 10.1097/00000421-200208000-00011. Am J Clin Oncol. 2002. PMID: 12151968

5

Clinical characteristics of gestational trophoblastic disease at a single institute.

Alici S, Eralp Y, Saip P, Argon A, Basaran M, Topuz E, Aydiner A. Alici S, et al. Tohoku J Exp Med. 2002 Jun;197(2):95-100. doi: 10.1620/tjem.197.95. Tohoku J Exp Med. 2002. PMID: 12233789 Free article.

6

Prognostic factors in localized aggressive non-Hodgkin's lymphoma.

Alici S, Bavbek SE, Kaytan E, Eralp Y, Onat H. Alici S, et al. Am J Clin Oncol. 2003 Feb;26(1):1-5. doi: 10.1097/00000421-200302000-00001. Am J Clin Oncol. 2003. PMID: 12576915

7

Colorectal cancer in young patients: characteristics and outcome.

Alici S, Aykan NF, Sakar B, Bulutlar G, Kaytan E, Topuz E. Alici S, et al. Tohoku J Exp Med. 2003 Feb;199(2):85-93. doi: 10.1620/tjem.199.85. Tohoku J Exp Med. 2003. PMID: 12705353 Free article.

8

Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).

Alici S, Saip P, Eralp Y, Aydiner A, Topuz E. Alici S, et al. Am J Clin Oncol. 2003 Aug;26(4):358-62. doi: 10.1097/01.COC.0000020590.62677.E0. Am J Clin Oncol. 2003. PMID: 12902885 Clinical Trial.

9

Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.

Alici S, Kaya S, Izmirli M, Tuncer I, Doğan E, Ozbek H, Sayarlioglu H. Alici S, et al. Med Sci Monit. 2006 May;12(5):CR221-9. Med Sci Monit. 2006. PMID: 16641880

10

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma without complete response to first-line therapy.

Alici S, Bavbek S, Basaran M, Onat H. Alici S, et al. Adv Ther. 2006 Jul-Aug;23(4):534-42. doi: 10.1007/BF02850042. Adv Ther. 2006. PMID: 17050496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters